Wei He

Prof. Wei He


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2025 in Signal Transduction and Targeted Therapy
Verified
Journal Article
Open access
HLHui Liu
Hui Liu
SWShuo Wang
Shuo Wang
JWJianhua Wang
Jianhua Wang
XGXin Guo
Xin Guo
YSYujing Song
Yujing Song
LYLei-Lei Yang
Lei-Lei Yang
Energy metabolism is indispensable for sustaining physiological functions in living organisms and assumes a pivotal role across physiological and pathological conditions. This review provides an extensive overview of advancements in energy metabolism research, elucidating critical pathways such as glycolysis, oxidative phosphorylation, fatty acid metabolism, and amino acid metabolism, along with their intricate regulatory mechanisms. The homeostatic balance of these processes is crucial; however, in pathological states such as neurodegenerative diseases, autoimmune disorders, and cancer, extensive metabolic reprogramming occurs, resulting in impaired glucose metabolism and mitochondrial dysfunction, which accelerate disease progression. Recent investigations into key regulatory pathways, including mechanistic target of rapamycin, sirtuins, and adenosine monophosphate-activated protein kinase, have considerably deepened our understanding of metabolic dysregulation and opened new avenues for therapeutic innovation. Emerging technologies, such as fluorescent probes, nano-biomaterials, and metabolomic analyses, promise substantial improvements in diagnostic precision. This review critically examines recent advancements and ongoing challenges in metabolism research, emphasizing its potential for precision diagnostics and personalized therapeutic interventions. Future studies should prioritize unraveling the regulatory mechanisms of energy metabolism and the dynamics of intercellular energy interactions. Integrating cutting-edge gene-editing technologies and multi-omics approaches, the development of multi-target pharmaceuticals in synergy with existing therapies such as immunotherapy and dietary interventions could enhance therapeutic efficacy. Personalized metabolic analysis is indispensable for crafting tailored treatment protocols, ultimately providing more accurate medical solutions for patients. This review aims to deepen the understanding and improve the application of energy metabolism to drive innovative diagnostic and therapeutic strategies.

14 October 2025 in Molecular Cancer
Verified
Journal Article
Open access
PDF file
YLYuan-Tong Liu
Yuan-Tong Liu
YWYun-Long Wang
Yun-Long Wang
SWShuo Wang
Shuo Wang
JLJia-Jun Li
Jia-Jun Li
WHWei He
Wei He
XWXiangbo Wan
Xiangbo Wan
The revolution in cancer immunotherapy, particularly through immune checkpoint inhibitors (ICIs), underscores the significant role of the tumor microenvironment (TME) in determining therapeutic outcomes. At the heart of this is the classification of tumors into “cold” and “hot”, which significantly influences the efficacy of immunotherapy. “Cold” tumors are characterized by scant immune cell infiltration and an immunosuppressive TME, which effectively evades immune detection and resists ICIs. In contrast, “hot” tumors, characterized by abundant immune cells and a proinflammatory environment, are more receptive to immunotherapeutic approaches. This review comprehensively examines the molecular and cellular foundations of the “cold” tumor phenotype, delving into the mechanisms of camouflage (impeding immune priming and infiltration), coercion (suppressing immune functions)​​, and ​​cytoprotection (resisting inflammatory death)​​ that contribute to maintaining immune silence. Furthermore, it critically evaluates emerging strategies for converting “cold” tumors to “hot”, immune-reactive entities, including the role of biomaterials in remodeling the TME to increase the effectiveness of immunotherapy. Through an in-depth exploration of these foundational mechanisms and therapeutic advancements, this review seeks to shed light on the way forward in cancer treatment, framing the transformation of “cold” tumors to “hot” tumors as a crucial approach to enhancing the reach of immunotherapy to a broader array of cancer types.

22 January 2026 in Medcomm
Verified
Journal Article
Open access
XGXin Guo
Xin Guo
HLHui Liu
Hui Liu
YSYu‐Jing Song
Yu‐Jing Song
JWJian‐Hua Wang
Jian‐Hua Wang
DLDanfeng Liu
Danfeng Liu
SWShuo Wang
Shuo Wang
The advent of neuroimmunology has dismantled the traditional doctrine of the brain's immune privilege, uncovering a sophisticated and dynamic bidirectional regulatory interplay between the nervous and immune systems. This review synthesizes pivotal advances in neuroimmunology, integrating recent anatomical and molecular discoveries to refine the understanding of neuro‐immune communication. It highlights the pathological roles of neurotransmitters, cytokines, and their signaling networks in neurodegenerative, psychiatric, and neoplastic diseases, while critically examining contested regulatory mechanisms. The review further evaluates the clinical translational potential and challenges of innovative strategies such as vagus nerve stimulation, optogenetics, multiomics sequencing, and cytokine‐targeted therapies. By integrating multidisciplinary perspectives, this review consolidates a theoretical framework for neuro‐immune research and provides insights into precision medicine for related diseases. On the basis of synthesizing existing knowledge, it proposes promising research directions, identifies priorities and potential challenges for future investigations, and emphasizes the value of neuro‐immune mechanisms in guiding therapeutic development—including target identification, design of individualized treatment strategies, and cross‐disciplinary collaborative innovation to advance clinical interventions for neuro‐immune diseases. Finally, the review delves into the recent advances and challenges in combined neuromodulation‐immunotherapy strategies.

12 June 2024 in Heliyon
Verified
Journal Article
Open access
KFKun Fu
Kun Fu
LYLei-Lei Yang
Lei-Lei Yang
NGNing Gao
Ning Gao
PLPengbi Liu
Pengbi Liu
BXBo Xue
Bo Xue
XWXuejun Wen
Xuejun Wen
Simulated body fluid (SBF) is widely utilized in preclinical research for estimating the mineralization efficacy of biomaterials. Therefore, it is of great significance to construct an efficient and stable SBF mineralization system. The conventional SBF solutions cannot maintain a stable pH value and are prone to precipitate homogeneous calcium salts at the early stages of the biomimetic process because of the release of gaseous CO2. In this study, a simple but efficient five times SBF buffered by 5 % CO2 was developed and demonstrated to achieve excellent mineralized microstructure on a type of polymer-aligned nanofibrous scaffolds, which is strikingly similar to the natural human bone tissue. Scanning electron microscopy and energy-dispersive X-ray examinations indicated the growth of heterogeneous apatite with a high-calcium-to-phosphate ratio on the aligned nanofibers under 5 times SBF buffered by 5 % CO2. Moreover, X-ray diffraction spectroscopy and Fourier transform infrared analyses yielded peaks associated with carbonated hydroxyapatite with less prominent crystallization. In addition, the biomineralized aligned polycaprolactone nanofibers demonstrated excellent cell attachment, alignment, and proliferation characteristics in vitro. Overall, the results of this study showed that 5 × SBFs buffered by 5 % CO2 partial pressure are attractive alternatives for the efficient biomineralization of scaffolds in bone tissue engineering, and could be used as a model for the prediction of the bone-bonding bioactivity of biomaterials.

2 April 2025 in Advanced Fiber Materials
Verified
Journal Article
Closed access
PDF file
XWXiuhui Wang
Xiuhui Wang
MSMingkui Shen
Mingkui Shen
MMMengze Ma
Mengze Ma
HZHuiying Zhang
Huiying Zhang
CSChaochen Shi
Chaochen Shi
Yazhou ChenYazhou Chen
Yazhou Chen

13 April 2022 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
NLNa Li
Na Li
QDQiuzheng Du
Qiuzheng Du
ZJZiwei Jing
Ziwei Jing
LXLianping Xue
Lianping Xue
WHWei He
Wei He
ZSZhi Sun
Zhi Sun